Penumbra (PEN) Non-Current Deferred Tax Liability (2019)

Penumbra (PEN) posted quarterly Non-Current Deferred Tax Liability of $6.3 million for Q2 2019.

Penumbra (PEN) Non-Current Deferred Tax Liability (2019) Analysis & Trends

Penumbra (PEN) has reported Non-Current Deferred Tax Liability for 1 consecutive years, with $6.3 million the latest figure, recorded in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn
10	Penumbra	12.80 Bn	12.14 Bn	264.94 Mn

Download Data

Date	Value
Jun 30, 2019	6.29 Mn
Jun 30, 2019	6.29 Mn